S.C. Ropharma Reports Full Year 2024 Earnings

Simply Wall St · 3d ago

S.C. Ropharma (BVB:RPH) Full Year 2024 Results

Key Financial Results

  • Revenue: RON1.33b (up 19% from FY 2023).
  • Net loss: RON1.73m (down by 122% from RON7.72m profit in FY 2023).
We've discovered 3 warning signs about S.C. Ropharma. View them for free.
earnings-and-revenue-history
BVB:RPH Earnings and Revenue History May 10th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

S.C. Ropharma shares are down 5.7% from a week ago.

Risk Analysis

Don't forget that there may still be risks. For instance, we've identified 3 warning signs for S.C. Ropharma (2 are significant) you should be aware of.